...
首页> 外文期刊>Journal of Medicinal Chemistry >Increasing C-Terminal Hydrophobicity Improves the Cell Permeability and Antiproliferative Activity of PACE4 Inhibitors against Prostate Cancer Cell Lines
【24h】

Increasing C-Terminal Hydrophobicity Improves the Cell Permeability and Antiproliferative Activity of PACE4 Inhibitors against Prostate Cancer Cell Lines

机译:增加的C末端疏水性提高了PACE4抑制剂对前列腺癌细胞系的细胞渗透性和抗增殖活性

获取原文
获取原文并翻译 | 示例

摘要

The serine protease, PACE4, is a proprotein convertase that plays a substantial role in malignancy of prostate cancer. Our initial selective PACE4 inhibitor (Ac-LLLLRVKR-NH2) has evolved to the current lead compound C23 (Ac-DLeu-LLLRVK-Amba), which is active both in vitro and in vivo. By screening natural residues, except Cys, in C-terminal P1' position, it was established that increasing hydrophobicity was improving cell permeability, which was directly translated into PCa cells antiproliferative activity. This cell antiproliferation enhancement seems independent from effect of P1' residue on PACE4 affinity. Replacement of PI-Amba of C23 by Acpa ((S)-2-amino-3-(4-carbamimidoylphenyl)propanoic acid) followed by addition of tryptamine in P1' resulted in compound 32 exhibiting superior PCa cells antiproliferative activity over the reference compound C23 (3-fold). This study sheds light on key factors that improve cell penetrating property and antiproliferative activity of PACE4 inhibitors.
机译:丝氨酸蛋白酶Pace4是一种普罗基蛋白转化酶,其在前列腺癌恶性肿瘤中起着重要作用。我们的初始选择性PACE4抑制剂(AC-LLLLRVKR-NH2)已经进化到当前的铅化合物C23(AC-DLEU-LLLRRVK-AMBA),其在体外和体内活跃。通过筛选除Cys外,在C末端P1'位置之外,确定增加疏水性正在提高细胞渗透性,其直接翻译成PCA细胞抗增殖活性。该细胞抗溶解增强似乎是独立于P1'残留对PACE4亲和力的影响。通过ACPA((S)-2-氨基-3-(4-氨基氨基-3-(4-氨基氨基-3-(4-氨基甲酰)丙酸)的替代C23的PI-AMBA,然后在P1'中加入木粉胺,得到化合物32,在参考化合物上表现出优异的PCA细胞抗增殖活性C23(3倍)。本研究揭示了改善细胞穿透性和PACE4抑制剂抗增殖活性的关键因素。

著录项

  • 来源
    《Journal of Medicinal Chemistry 》 |2018年第18期| 共11页
  • 作者单位

    Univ Sherbrooke Fac Sci Inst Pharmacol Sherbrooke Dept Chim 3001 12e Ave Nord Sherbrooke PQ J1H 5N4 Canada;

    Univ Sherbrooke Inst Pharmacol Sherbrooke Dept Chirurg Urol 3001 12e Ave Nord Sherbrooke PQ J1H 5N4 Canada;

    Univ Sherbrooke Inst Pharmacol Sherbrooke Dept Chirurg Urol 3001 12e Ave Nord Sherbrooke PQ J1H 5N4 Canada;

    Univ Sherbrooke Inst Pharmacol Sherbrooke Dept Chirurg Urol 3001 12e Ave Nord Sherbrooke PQ J1H 5N4 Canada;

    Univ Sherbrooke Fac Sci Inst Pharmacol Sherbrooke Dept Chim 3001 12e Ave Nord Sherbrooke PQ J1H 5N4 Canada;

    Univ Sherbrooke Inst Pharmacol Sherbrooke Dept Chirurg Urol 3001 12e Ave Nord Sherbrooke PQ J1H 5N4 Canada;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学 ;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号